Wai Chun Bio-Technology (HKSE:00660) Beta: 0.0113 (As of Aug. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00660 Wai Chun Bio-Technology Ltd HKSE:00660
23 GF Score
Price HK$0.42
! 6 Warning Signs
View Full Analysis

What is Wai Chun Bio-Technology Beta?

Wai Chun Bio-Technology HKSE:00660 23 Beta is 0.0113 as of Aug. 18, 2026. GuruFocus rates HKSE:00660 with a GF Score™ of 23/100. The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-18), Wai Chun Bio-Technology's Beta is 0.0113.


Wai Chun Bio-Technology  (HKSE:00660) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Wai Chun Bio-Technology Beta Related Terms


Wai Chun Bio-Technology Beta Historical Data

* Premium members only.

The historical data trend for Wai Chun Bio-Technology's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wai Chun Bio-Technology Beta Chart

Wai Chun Bio-Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Jun22 Jun23 Jun24 Jun25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.39 0.42 0.27 0.16 0.02

Wai Chun Bio-Technology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.16 -0.10 0.02 -0.12

HKSE:00660 vs DOW: Beta Comparison

For the Chemicals subindustry, Wai Chun Bio-Technology's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wai Chun Bio-Technology Beta vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Wai Chun Bio-Technology's Beta distribution charts can be found below:

* The bar in red indicates where Wai Chun Bio-Technology's Beta falls into.


HKSE:00660
23GF Score
Wai Chun Bio-Technology Ltd HKSE:00660
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wai Chun Bio-Technology Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.0113 mean?
Wai Chun Bio-Technology (HKSE:00660) has a Beta of 0.0113 as of Aug. 18, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Wai Chun Bio-Technology and its competitors.
Is Wai Chun Bio-Technology's Beta too high?
Wai Chun Bio-Technology's current Beta is 0.0113. Overall, Wai Chun Bio-Technology has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Wai Chun Bio-Technology's Beta compare to DOW?
Wai Chun Bio-Technology's Beta of 0.0113 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Chemicals company?
A good Beta depends on the Chemicals industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Wai Chun Bio-Technology and its competitors. Wai Chun Bio-Technology's current Beta is 0.0113. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wai Chun Bio-Technology stock overvalued right now?
Wai Chun Bio-Technology (HKSE:00660) has a current Beta of 0.0113. The current Beta is 0.0113. Wai Chun Bio-Technology's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Wai Chun Bio-Technology (HKSE:00660), the current Beta is 0.0113 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Wai Chun Bio-Technology Business Description

Address 26 Harbour Road, Rooms 4001-02, 40th Floor, China Resources Building, Wanchai, Hong Kong, HKG
Wai Chun Bio-Technology Ltd is an investment holding company. The company has one reportable segmentbeing the manufacturing and sale of modified starch and other biochemical products. It is involved in the manufacturing and sale of modified starch and other biochemical products. Geographically, it derives a majority of its revenue from the People's Republic of China. The company also has its presence in Hong Kong.
23GF Score

Get the complete analysis for HKSE:00660

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.42
Price